These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 3033023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid.
    Li JZ, Sharma R, Dileepan KN, Savin VJ.
    Kidney Int; 1994 Oct; 46(4):1025-30. PubMed ID: 7861697
    [Abstract] [Full Text] [Related]

  • 5. Oxidant membrane injury by the neutrophil myeloperoxidase system. I. Characterization of a liposome model and injury by myeloperoxidase, hydrogen peroxide, and halides.
    Sepe SM, Clark RA.
    J Immunol; 1985 Mar; 134(3):1888-95. PubMed ID: 2981925
    [Abstract] [Full Text] [Related]

  • 6. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis.
    Heeringa P, van Goor H, Moshage H, Klok PA, Huitema MG, de Jager A, Schep AJ, Kallenberg CG.
    Kidney Int; 1998 Feb; 53(2):382-93. PubMed ID: 9461097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.
    Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, Kallenberg CG.
    J Exp Med; 1993 Apr 01; 177(4):905-14. PubMed ID: 8384653
    [Abstract] [Full Text] [Related]

  • 12. Myeloperoxidase in kidney disease.
    Malle E, Buch T, Grone HJ.
    Kidney Int; 2003 Dec 01; 64(6):1956-67. PubMed ID: 14633118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut.
    Heeringa P, Foucher P, Klok PA, Huitema MG, Tervaert JW, Weening JJ, Kallenberg CG.
    Am J Pathol; 1997 Jul 01; 151(1):131-40. PubMed ID: 9212739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Down-regulation of human natural killer activity against tumors by the neutrophil myeloperoxidase system and hydrogen peroxide.
    El-Hag A, Clark RA.
    J Immunol; 1984 Dec 01; 133(6):3291-7. PubMed ID: 6092470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inactivation of myocardial dihydrolipoamide dehydrogenase by myeloperoxidase systems: effect of halides, nitrite and thiol compounds.
    Gutierrez-Correa J, Stoppani AO.
    Free Radic Res; 1999 Feb 01; 30(2):105-17. PubMed ID: 10193578
    [Abstract] [Full Text] [Related]

  • 20. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, Hickey MJ, Holdsworth SR.
    J Am Soc Nephrol; 2006 Jul 01; 17(7):1940-9. PubMed ID: 16769746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.